Point72 Asset Management’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-72
Closed -$35 2989
2023
Q2
$35 Buy
+72
New +$59 ﹤0.01% 2084
2022
Q2
Sell
-417,559
Closed -$2.97M 1710
2022
Q1
$2.97M Buy
+417,559
New +$3.45M 0.01% 809

Other funds holding CELL

Point72 Asset Management's CELL Position: Q3 2023 in Review

Point72 Asset Management sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 72 shares — an estimated $35 sold.

Point72 Asset Management first reported a position in CELL in Q1 2022 and held it in 2 quarters. The position peaked at $2.97M in Q1 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • Point72 Asset Management reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Point72 Asset Management sold 72 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $35.
  • Point72 Asset Management first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Point72 Asset Management's PhenomeX Inc. Common Stock position peaked at $2.97M in Q1 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on Point72 Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.